Big trouble at Commonwealth BioTech. Big paycuts at Star Scientific. The buying binge continues at Apple REIT Nine. And a new CFO at CarMax. Plus earnings from EVB, where nonperforming assets rose nearly 60 percent.
Big trouble at Commonwealth BioTech. Big paycuts at Star Scientific. The buying binge continues at Apple REIT Nine. And a new CFO at CarMax. Plus earnings from EVB, where nonperforming assets rose nearly 60 percent.
Update your browser to view this website correctly. Update my browser now